Genetic polymorphisms of cytochrome P4502B6 gene in Han Chinese

被引:41
作者
Guan, Su
Huang, Min
Chan, Eli
Chen, Xiao
Duan, Wei
Zhou, Shu-Feng
机构
[1] Sun Yat Sen Univ, Sch Pharmaceut Sci, Inst Clin Pharmacol, Guangzhou 510080, Peoples R China
[2] Natl Univ Singapore, Fac Sci, Dept Pharm, Singapore 117543, Singapore
[3] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pharm, Guangzhou 510080, Peoples R China
[4] Natl Univ Singapore, Fac Med, Dept Biochem, Singapore 117548, Singapore
基金
中国国家自然科学基金;
关键词
CYP2B6; Chinese; single nucleotide polymorphism; ethnicity;
D O I
10.1016/j.ejps.2006.04.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cytochrome P450 (CYP2B6) is an important enzyme that metabolizes more than eight compounds and about 3.0% of therapeutic drugs. The genetic polymorphisms of CYP2B6 have earlier been studied in Caucasian, Japanese and Korean, but the data are lacking for Han Chinese. The aim of this study was to investigate the frequencies of allelic variants of CYP2B6 in healthy Han Chinese and compare with those in other ethnic groups reported in the literature. Polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP) method was used to test the five common non-synonymous single nucleotide polymorphisms (SNPs) of CYP2B6 gene, namely, 64C > T, 516G > T, 777C > A, 785A > G and 1459C > T in unrelated healthy Han Chinese (n = 193). The study demonstrated that the frequencies of 64C > T, 516G > T, 777C > A, 785A > G and 1459C > T SNPs in Han Chinese were 0.03, 0.21, 0, 0.28 and 0.003, respectively. The frequencies of all five SNPs tested in female were higher than those in male, but the statistical difference was insignificant (P > 0.05). Compared to the data reported in the literature, the frequencies of common CYP2B6 allelic variants in Chinese are similar to those of other Asian populations including Japanese and Korean, but markedly different from those in Caucasians. These results indicate the presence of marked ethnic difference in CYP2B6 SNP frequencies between Chinese and Caucasian. Further studies are required to explore the impact of these SNPs of CYP2B6 gene on the clinical response (efficacy and toxicity) to drugs that are substrates for CYP2B6 in patients. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:14 / 21
页数:8
相关论文
共 57 条
[1]   A single nucleotide polymorphism of CYP2B6 found in Japanese enhances catalytic activity by autoactivation [J].
Ariyoshi, N ;
Miyazaki, M ;
Toide, K ;
Sawamura, Y ;
Kamataki, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 281 (05) :1256-1260
[2]   Interpatient variability in the pharmacokinetics of the HIV non-nucleoside reverse transcriptase inhibitor efavirenz:: the effect of gender, race, and CYP2B6 polymorphism [J].
Burger, D ;
van der Heiden, I ;
la Porte, C ;
van der Ende, M ;
Groeneveld, P ;
Richter, C ;
Koopmans, P ;
Kroon, F ;
Sprenger, H ;
Lindemans, J ;
Schenk, P ;
van Schaik, R .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 61 (02) :148-154
[3]   Constitutive androstane receptor and pregnane X receptor gene expression in human liver: Interindividual variability and correlation with CYP2B6 mRNA levels [J].
Chang, TKH ;
Bandiera, SM ;
Chen, J .
DRUG METABOLISM AND DISPOSITION, 2003, 31 (01) :7-10
[4]  
CHANG TKH, 1993, CANCER RES, V53, P5629
[5]   Haplotype structure and allele frequencies of CYP2B6 in a Korean population [J].
Cho, JY ;
Lim, HS ;
Chung, JY ;
Yu, KS ;
Kim, JR ;
Shin, SG ;
Jang, IJ .
DRUG METABOLISM AND DISPOSITION, 2004, 32 (12) :1341-1344
[6]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[7]   An interethnic comparison of polymorphisms of the genes encoding drug-metabolizing enzymes and drug transporters: Experience in Singapore [J].
Chowbay, B ;
Zhou, SF ;
Lee, EJD .
DRUG METABOLISM REVIEWS, 2005, 37 (02) :327-378
[8]  
Code EL, 1997, DRUG METAB DISPOS, V25, P985
[9]   Influence of ABCB1, ABCC1, ABCC2, and ABCG2 haplotypes on the cellular exposure of nelfinavir in vivo [J].
Colombo, S ;
Soranzo, N ;
Rotger, M ;
Sprenger, R ;
Bleiber, G ;
Furrer, H ;
Buclin, T ;
Goldstein, D ;
Décosterd, L ;
Telenti, A .
PHARMACOGENETICS AND GENOMICS, 2005, 15 (09) :599-608
[10]   Metabolism of tamoxifen by recombinant human cytochrome P450 enzymes:: Formation of the 4-hydroxy, 4′-hydroxy and N-desmethyl metabolites and isomerization of trans-4-hydroxytamoxifen [J].
Crewe, HK ;
Notley, LM ;
Wunsch, RM ;
Lennard, MS ;
Gillam, EMJ .
DRUG METABOLISM AND DISPOSITION, 2002, 30 (08) :869-874